KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Capital Employed (2016 - 2025)

AbbVie (ABBV) has disclosed Return on Capital Employed for 13 consecutive years, with 0.17% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 8.0% to 0.17% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.17%, a 8.0% increase, with the full-year FY2025 number at 0.17%, up 7.0% from a year prior.
  • Return on Capital Employed was 0.17% for Q4 2025 at AbbVie, up from 0.09% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.17% in Q2 2023 to a low of 0.09% in Q4 2024.
  • A 5-year average of 0.14% and a median of 0.14% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -8bps in 2021, then grew 8bps in 2025.
  • AbbVie's Return on Capital Employed stood at 0.16% in 2021, then grew by 3bps to 0.16% in 2022, then fell by -20bps to 0.13% in 2023, then tumbled by -30bps to 0.09% in 2024, then skyrocketed by 83bps to 0.17% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Return on Capital Employed are 0.17% (Q4 2025), 0.09% (Q3 2025), and 0.11% (Q2 2025).